İVEK | İlaç, Eczacılık, Sağlık Bilim ve Teknolojileri Vakfı

What İVEK | İlaç, Eczacılık, Sağlık Bilim ve Teknolojileri Vakfı does

İVEK (İlaç, Eczacılık, Sağlık Bilim ve Teknolojileri Vakfı) is a Turkish non-profit foundation established in 2016 (with predecessor association roots from 2012-2013) operating in the pharmaceuticals, pharmacy, and health sciences sectors. Headquartered in Bağcılar, Istanbul, it serves as a convening platform for 2,128 registered members across four primary constituencies: independent pharmacists, the pharmaceutical industry, academia and research institutions, and government regulators (TİTCK, TÜSEB, TÜBİTAK, SGK, Ministry of Health). The foundation is governed by 3 boards, 12 commissions, and 19 working groups, and is led by figures with senior regulatory and academic backgrounds, including a former head of the General Directorate of Pharmaceuticals and Pharmacy and a former Ankara University Rector who also sits on the Presidential Health and Food Policies Board.

İVEK's "products" are non-commercial programs and platforms rather than technology offerings. The organization runs international congresses (International İVEK Biotechnology Congress and International Pharmaceutical and Pharmacy Congress), an educational platform (İVEK Akademi) hosting webinars and professional development, a YouTube-based media channel (İVEK TV) featuring interviews and educational content, and a youth engagement program (Genç İVEK). The foundation does not sell commercial products; its go-to-market is community-led, with member services, content publishing, and event-driven stakeholder engagement. Revenue is not publicly disclosed and the foundation does not report funding rounds; operations are funded through mechanisms typical of Turkish vakıf entities (membership dues, sponsorships, grants).

The foundation's strategic positioning centers on being a unique neutral convener in Turkey's pharmaceutical ecosystem, with established international connections (Saudi Arabia Ministry of Health visit, OrphanDrug Congress USA participation) and disease-specific advocacy work (rare diseases with Sanofi Genzyme and Ankara University). İVEK functions as a policy dialogue and knowledge-sharing institution rather than a commercial enterprise, and its competitive position derives from institutional access to senior regulators and a multi-stakeholder governance structure that is difficult to replicate.

Name

İVEK | İlaç, Eczacılık, Sağlık Bilim ve Teknolojileri Vakfı

Legal name

İlaç, Eczacılık, Sağlık Bilim ve Teknolojileri Vakfı

Website

https://ivek.org.tr

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

51–100 employees

Short description

İVEK is a Turkish non-profit foundation convening 2,128 members across pharmacists, pharmaceutical industry, academia, and government regulators, through international congresses, the İVEK Akademi educational platform, İVEK TV media channel, and Genç İVEK youth programming.

Ownership category

akta.pro rank

Headquarters

HQ city

İstanbul

HQ country

Türkiye

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Foundation Operations: İVEK operates as a non-profit foundation (vakıf) that generates value through member services, organizing conferences and congresses, publishing content via İVEK TV and İVEK Akademi, and facilitating dialogue between the pharmaceutical industry, pharmacy profession, academia, and government regulators.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

İVEK is a non-profit foundation that convenes pharmacists, pharmaceutical industry professionals, academics, and government regulators in Turkey through international congresses, educational programs (İVEK Akademi), a YouTube-based media channel (İVEK TV), and a youth engagement wing (Genç İVEK). Its core activities center on policy dialogue, professional development, and knowledge exchange within the pharmaceutical and health sciences sectors rather than commercial product sales. The foundation coordinates 3 boards, 12 commissions, and 19 working groups serving 2,128 members.

Product overview

İVEK (İlaç, Eczacılık, Sağlık Bilim ve Teknolojileri Vakfı) is a foundation organization focused on pharmaceuticals, pharmacy, health sciences, and technologies in Turkey. The organization does not offer a commercial product portfolio but instead operates as an advocacy, education, and policy body within the pharmaceutical and healthcare sectors. Its primary activities include organizing international congresses (such as the Uluslararası İlaç ve Eczacılık Kongresi and Uluslararası İVEK Biyoteknoloji Kongresi), running İVEK Akademi for educational programs, producing content through İVEK TV, and coordinating youth engagement via Genç İVEK. The organization also maintains various commissions and working groups focused on industry issues, legislation, and health technology.

Differentiator

Problem solved

Functional benefit

Brands

• İVEK Akademi: Educational platform operated by İVEK for organizing webinars, training programs, and professional development activities in the pharmaceutical and health sectors.
• Genç İVEK

Products and services

• İVEK Akademi An educational platform organized by İVEK that delivers webinars, discussions, and training programs for pharmacists and healthcare professionals on topics including pharmaceutical regulations, food supplements, and industry developments.
• İVEK TV A YouTube-based media channel operated by İVEK that publishes interviews, panel discussions, and educational video content related to the pharmaceutical, pharmacy, and health sciences sectors.
• Genç İVEK A youth-focused initiative under İVEK that engages young pharmacists and healthcare students through professional development activities, panel discussions, and institutional visits.
• Uluslararası İlaç ve Eczacılık Kongresi (International Pharmaceutical and Pharmacy Congress) An international congress organized by İVEK that brings together pharmacists, pharmaceutical industry representatives, academics, and government officials to discuss pharmaceutical and health sector developments, regulatory frameworks, and future goals.
• Uluslararası İVEK Biyoteknoloji Kongresi (İVEK BİO) An international biotechnology congress organized by İVEK focusing on biotechnological drug development, nanobiotechnology, gene therapy, and related health technology topics, with participation from regulators, academics, and industry.

Quantifiable outcome

• 3 Boards, 12 Commissions, 19 Working Groups providing comprehensive sectoral coverage
• +1 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

14 partnerships are on record, tiered core, flagship and minor.

• TÜSAP (Sağlık Teknolojileri Derneği)coreStrategic or Co-development Partner · 12 June 2026İVEK participated in TÜSAP's 47th Vision Meeting on Health Technologies held at BHT CLINIC Istanbul Tema Hospital with the theme 'New Developments and Applications in Healthy Aging in Medicine and Pharmacy'.
• İKMİB (İstanbul Kimyevi Maddeler ve Mamulleri İhracatçıları Birliği)coreStrategic or Co-development Partner · 11 June 2026İVEK participated in the Drug Committee and Medical Device Committee Meetings organized by İKMİB, representing the foundation's interests in export-oriented pharmaceutical industry discussions.
• Ankara Üniversitesi Nadir Hastalıklar Uygulama ve Araştırma MerkezicoreStrategic or Co-development Partner · 9 January 2024İVEK Foundation Board members and Pharmaceutical Industry and Technology Commission members visited the center to learn about ongoing work and projects, evaluating potential collaborations. Cooperation focused on rare diseases research and awareness activities.
• Ministry of Health Saudi ArabiaflagshipStrategic or Co-development Partner · 30 January 2017Saudi Arabia's Health Minister Tevfik er-Rebia and delegation visited İVEK as part of their trip to Turkey to examine the health transformation model. The minister was invited to İVEK's 3rd International Pharmaceutical and Pharmacy Congress.
• Sanofi GenzymecoreStrategic or Co-development PartnerSanofi Genzyme contributed to İVEK's rare disease awareness content. The company develops treatments for rare diseases and works with ecosystem stakeholders including İVEK for disease awareness initiatives.
• Çapa MedikalcoreOthersÇapa Medikal Chairman Zekeriya Avşar serves on İVEK's Board of Directors. The company actively participates in İVEK activities and contributed to earthquake relief logistics in collaboration with the foundation.
• Sultanlar HoldingcoreOthersSultanlar Holding Chairman Mücahit Yıldız serves as İVEK's Board Member. İVEK's General Manager visited him at Sultanlar Holding headquarters.
• TİTCK (Türkiye İlaç ve Tıbbi Cihaz Kurumu)flagshipStrategic or Co-development PartnerİVEK collaborated with TİTCK for the International İVEK Biotechnology Congress. The agency is a key stakeholder in pharmaceutical policy discussions organized by İVEK.
• TÜBİTAKflagshipStrategic or Co-development PartnerTÜBİTAK participated in İVEK's International Biotechnology Congress. The agency supports high-tech R&D in biotechnology and pharmaceuticals.
• SGK (Sosyal Güvenlik Kurumu)flagshipStrategic or Co-development PartnerSGK General Health Insurance Director participated in İVEK's International Biotechnology Congress, contributing to discussions on drug reimbursement and pricing policies.
• TÜSEB (Türkiye Sağlık Enstitüleri Başkanlığı)flagshipStrategic or Co-development PartnerTÜSEB activities were shared during İVEK's International Biotechnology Congress, representing health biotechnology policy coordination.
• Anadolu Ajansı (AA)minorGTM or Marketing PartnerİVEK management visited Anadolu Agency Istanbul Regional Director to promote the foundation's activities and International Biotechnology Congress.
• Posta GazetesiminorGTM or Marketing PartnerCoverage of İVEK's BIO Türkiye participation in Posta newspaper.
• GazetebirlikminorGTM or Marketing PartnerCoverage of İVEK's BIO Türkiye participation in Gazetebirlik newspaper.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• IFPMA: International Federation of Pharmaceutical Manufacturers and Associations. Functions as a global industry convener analogous to İVEK's domestic convening role, but at global scale and with industry membership rather than academic/pharmacy breadth.
• EFPIA: European Federation of Pharmaceutical Industries and Associations. Comparable as a multi-country pharma association platform advocating for the industry with regulators, but anchored in EU policy rather than Turkish pharma ecosystem.
• PhRMA: US pharmaceutical research and manufacturers association. Comparable in function as a national pharma industry convener and policy advocate, but operates at much larger scale and within a different regulatory environment than İVEK's Turkey-centric mission.

Others

• TÜBİTAK: Turkey's Scientific and Technological Research Council. İVEK has a flagship partnership with TÜBİTAK; TÜBİTAK is a major funder of biotech R&D that İVEK's ecosystem engages, making it an adjacent enabling institution rather than a direct competitor.

Direct peers

• İlaç Endüstrisi İşverenler Sendikası (İEİS): Pharmaceutical Industry Employers Association of Turkey. A direct peer in policy advocacy and sector representation for pharma manufacturers, with overlapping relationships with TİTCK and SGK that İVEK also convenes.
• Türk Eczacıları Birliği (TEB): The official Turkish Pharmacists' Association representing community pharmacists nationally. Highly comparable to İVEK's mission of supporting and advocating for the pharmacy profession, with overlapping member base and policy influence, though with a stronger statutory mandate.
• Sağlık Teknolojileri Derneği (TÜSAP): Health Technologies Association of Turkey; İVEK is already a documented partner. Both associations convene stakeholders on health technology policy, with overlapping membership in industry, academia, and government.
• Araştırmacı İlaç Firmaları Derneği (AİFD): Turkey's association of research-based pharmaceutical companies. Closely comparable to İVEK in convening the pharma industry with regulators and academics, but focused on the innovative-medicines industry side rather than pharmacy and broader health sciences.

Regional players

• Türk Tabipleri Birliği (TTB): Turkish Medical Association. Comparable as a national professional health association with policy advocacy and continuing-education mandates, but representing physicians rather than pharmacists and operating under a different statutory framework.
• Türkiye Sağlık Enstitüleri Başkanlığı (TÜSEB): Turkey's Health Institutes Presidency, a government body coordinating health biotechnology and pharmaceutical R&D policy. İVEK has a flagship partnership with TÜSEB; comparable in mission but operating as a state institution rather than a private foundation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/ivek_vakfi
• YouTubeyoutube.com/channel/UCUH3t_MaxsWn5iUHbccbsIw/featured
• LinkedInlinkedin.com/company/ivek-ila%C3%A7-eczac%C4%B1l%C4%B1k-sa%C4%9Fl%C4%B1k-bilim-ve-teknolojileri-vakf%C4%B1

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about İVEK | İlaç, Eczacılık, Sağlık Bilim ve Teknolojileri Vakfı